348 related articles for article (PubMed ID: 15308098)
1. Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction.
Jeon MS; Atfield A; Venuprasad K; Krawczyk C; Sarao R; Elly C; Yang C; Arya S; Bachmaier K; Su L; Bouchard D; Jones R; Gronski M; Ohashi P; Wada T; Bloom D; Fathman CG; Liu YC; Penninger JM
Immunity; 2004 Aug; 21(2):167-77. PubMed ID: 15308098
[TBL] [Abstract][Full Text] [Related]
2. Regulation of peripheral T cell tolerance by the E3 ubiquitin ligase Cbl-b.
Loeser S; Penninger JM
Semin Immunol; 2007 Jun; 19(3):206-14. PubMed ID: 17391982
[TBL] [Abstract][Full Text] [Related]
3. Activation of T cells: releasing the brakes by proteolytic elimination of Cbl-b.
Schmitz ML
Sci Signal; 2009 Jun; 2(76):pe38. PubMed ID: 19549983
[TBL] [Abstract][Full Text] [Related]
4. Essential role of E3 ubiquitin ligase activity in Cbl-b-regulated T cell functions.
Paolino M; Thien CB; Gruber T; Hinterleitner R; Baier G; Langdon WY; Penninger JM
J Immunol; 2011 Feb; 186(4):2138-47. PubMed ID: 21248250
[TBL] [Abstract][Full Text] [Related]
5. The E3 ubiquitin ligase Cbl-b regulates expansion but not functional activity of self-reactive CD4 T cells.
St Rose MC; Qui HZ; Bandyopadhyay S; Mihalyo MA; Hagymasi AT; Clark RB; Adler AJ
J Immunol; 2009 Oct; 183(8):4975-83. PubMed ID: 19801520
[TBL] [Abstract][Full Text] [Related]
6. Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b.
Bachmaier K; Krawczyk C; Kozieradzki I; Kong YY; Sasaki T; Oliveira-dos-Santos A; Mariathasan S; Bouchard D; Wakeham A; Itie A; Le J; Ohashi PS; Sarosi I; Nishina H; Lipkowitz S; Penninger JM
Nature; 2000 Jan; 403(6766):211-6. PubMed ID: 10646608
[TBL] [Abstract][Full Text] [Related]
7. Cbl-b deficiency prevents functional but not phenotypic T cell anergy.
Nguyen TTT; Wang ZE; Shen L; Schroeder A; Eckalbar W; Weiss A
J Exp Med; 2021 Jul; 218(7):. PubMed ID: 33974042
[TBL] [Abstract][Full Text] [Related]
8. E3 ubiquitin ligases as T cell anergy factors.
Mueller DL
Nat Immunol; 2004 Sep; 5(9):883-90. PubMed ID: 15334084
[TBL] [Abstract][Full Text] [Related]
9. Differential control of CD28-regulated in vivo immunity by the E3 ligase Cbl-b.
Krawczyk CM; Jones RG; Atfield A; Bachmaier K; Arya S; Odermatt B; Ohashi PS; Penninger JM
J Immunol; 2005 Feb; 174(3):1472-8. PubMed ID: 15661906
[TBL] [Abstract][Full Text] [Related]
10. E3 ubiquitin ligase Cbl-b regulates Pten via Nedd4 in T cells independently of its ubiquitin ligase activity.
Guo H; Qiao G; Ying H; Li Z; Zhao Y; Liang Y; Yang L; Lipkowitz S; Penninger JM; Langdon WY; Zhang J
Cell Rep; 2012 May; 1(5):472-82. PubMed ID: 22763434
[TBL] [Abstract][Full Text] [Related]
11. Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins.
Heissmeyer V; Macián F; Im SH; Varma R; Feske S; Venuprasad K; Gu H; Liu YC; Dustin ML; Rao A
Nat Immunol; 2004 Mar; 5(3):255-65. PubMed ID: 14973438
[TBL] [Abstract][Full Text] [Related]
12. The anergy induction of M3 muscarinic acetylcholine receptor-reactive CD4+ T cells suppresses experimental sialadenitis-like Sjögren's syndrome.
Asashima H; Tsuboi H; Takahashi H; Hirota T; Iizuka M; Kondo Y; Matsui M; Matsumoto I; Sumida T
Arthritis Rheumatol; 2015 May; 67(8):2213-25. PubMed ID: 25891013
[TBL] [Abstract][Full Text] [Related]
13. Visualizing the role of Cbl-b in control of islet-reactive CD4 T cells and susceptibility to type 1 diabetes.
Hoyne GF; Flening E; Yabas M; Teh C; Altin JA; Randall K; Thien CB; Langdon WY; Goodnow CC
J Immunol; 2011 Feb; 186(4):2024-32. PubMed ID: 21248249
[TBL] [Abstract][Full Text] [Related]
14. Egr-2 and Egr-3 are negative regulators of T cell activation.
Safford M; Collins S; Lutz MA; Allen A; Huang CT; Kowalski J; Blackford A; Horton MR; Drake C; Schwartz RH; Powell JD
Nat Immunol; 2005 May; 6(5):472-80. PubMed ID: 15834410
[TBL] [Abstract][Full Text] [Related]
15. Cutting edge: deficiency in the E3 ubiquitin ligase Cbl-b results in a multifunctional defect in T cell TGF-beta sensitivity in vitro and in vivo.
Wohlfert EA; Gorelik L; Mittler R; Flavell RA; Clark RB
J Immunol; 2006 Feb; 176(3):1316-20. PubMed ID: 16424156
[TBL] [Abstract][Full Text] [Related]
16. Cbl-b regulates the CD28 dependence of T-cell activation.
Chiang YJ; Kole HK; Brown K; Naramura M; Fukuhara S; Hu RJ; Jang IK; Gutkind JS; Shevach E; Gu H
Nature; 2000 Jan; 403(6766):216-20. PubMed ID: 10646609
[TBL] [Abstract][Full Text] [Related]
17. T cell activation threshold regulated by E3 ubiquitin ligase Cbl-b determines fate of inducible regulatory T cells.
Qiao G; Zhao Y; Li Z; Tang PQ; Langdon WY; Yang T; Zhang J
J Immunol; 2013 Jul; 191(2):632-9. PubMed ID: 23749633
[TBL] [Abstract][Full Text] [Related]
18. Cbl-b negatively regulates B cell antigen receptor signaling in mature B cells through ubiquitination of the tyrosine kinase Syk.
Sohn HW; Gu H; Pierce SK
J Exp Med; 2003 Jun; 197(11):1511-24. PubMed ID: 12771181
[TBL] [Abstract][Full Text] [Related]
19. Deltex1 promotes protein kinase Cθ degradation and sustains Casitas B-lineage lymphoma expression.
Hsu TS; Hsiao HW; Wu PJ; Liu WH; Lai MZ
J Immunol; 2014 Aug; 193(4):1672-80. PubMed ID: 25000980
[TBL] [Abstract][Full Text] [Related]
20. Control of the B cell-intrinsic tolerance programs by ubiquitin ligases Cbl and Cbl-b.
Kitaura Y; Jang IK; Wang Y; Han YC; Inazu T; Cadera EJ; Schlissel M; Hardy RR; Gu H
Immunity; 2007 May; 26(5):567-78. PubMed ID: 17493844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]